Robert E. Waltermire - Jan 16, 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Senior VP, Chief Pharma Dev.
Signature
/s/ Brian J. Lynch*
Stock symbol
MDGL
Transactions as of
Jan 16, 2024
Transactions value $
-$134,156
Form type
4
Date filed
1/18/2024, 01:45 PM
Previous filing
Dec 18, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Tax liability -$134K -550 -9.71% $243.92 5.12K Jan 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents withholding of shares as payment of the Reporting Person's tax liabilities incident to the vesting of restricted stock units granted to the Reporting Person on January 16, 2023.

Remarks:

*As attorney-in-fact for Reporting Person